Judd W. Moul

1990–2024 年に発表

別表記
JUDD W. MOUL
124
論文数
19,637
被引用数
87
h 指数
120
i10 指数

被引用数

Judd W. Moul の年別被引用数1928 年: 被引用 1 件1987 年: 被引用 1 件1991 年: 被引用 3 件1992 年: 被引用 3 件1993 年: 被引用 14 件1994 年: 被引用 8 件1995 年: 被引用 18 件1996 年: 被引用 28 件1997 年: 被引用 36 件1998 年: 被引用 52 件1999 年: 被引用 73 件2000 年: 被引用 76 件2001 年: 被引用 88 件2002 年: 被引用 100 件2003 年: 被引用 108 件2004 年: 被引用 145 件2005 年: 被引用 221 件2006 年: 被引用 195 件2007 年: 被引用 187 件2008 年: 被引用 180 件2009 年: 被引用 166 件2010 年: 被引用 157 件2011 年: 被引用 180 件2012 年: 被引用 164 件2013 年: 被引用 179 件2014 年: 被引用 184 件2015 年: 被引用 130 件2016 年: 被引用 139 件2017 年: 被引用 116 件2018 年: 被引用 81 件2019 年: 被引用 315 件2020 年: 被引用 278 件2021 年: 被引用 257 件2022 年: 被引用 168 件2023 年: 被引用 128 件2024 年: 被引用 192 件2025 年: 被引用 75 件2026 年: 被引用 2 件1929〜1986 年は被引用が無いため表示していません1988〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,116 件、この内訳の 35.2%イギリス: 引用元論文 361 件、この内訳の 6%カナダ: 引用元論文 341 件、この内訳の 5.7%ドイツ: 引用元論文 332 件、この内訳の 5.5%中国: 引用元論文 313 件、この内訳の 5.2%イタリア: 引用元論文 300 件、この内訳の 5%フランス: 引用元論文 210 件、この内訳の 3.5%オーストラリア: 引用元論文 176 件、この内訳の 2.9%オランダ: 引用元論文 176 件、この内訳の 2.9%ベルギー: 引用元論文 127 件、この内訳の 2.1%日本: 引用元論文 123 件、この内訳の 2.1%スイス: 引用元論文 117 件、この内訳の 2%
0%35.2%その他 21.9%

分野

  • Medicine72.1%
  • Biochemistry, Genetics and Molecular Biology18%
  • Chemistry2.5%
  • Computer Science2.4%
  • Neuroscience1.2%
  • Immunology and Microbiology0.8%
  • その他3%

トピック

  • Prostate Cancer Treatment and Research16.7%
  • Prostate Cancer Diagnosis and Treatment15.7%
  • Cancer, Lipids, and Metabolism2%
  • Radiopharmaceutical Chemistry and Applications1.9%
  • Advanced Radiotherapy Techniques1.8%
  • Cancer-related molecular mechanisms research1.7%
  • その他60.2%

共著者

全論文

検索で開く
  1. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification

    著者: , , , , , - Prostate Cancer and Prostatic Diseases 2023 被引用: 138

  2. Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    著者: , , , , , , , , , , , , , , , - The Journal of Urology 2007 被引用: 841

  3. Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , - Journal of Clinical Oncology 2014 被引用: 475

  4. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

    著者: , , , , , , , , , - The Journal of Urology 2018 被引用: 148

  5. A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)

    著者: , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 62

  6. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.

    著者: , , , , , , , , , , , , , , - 2000 被引用: 203

  7. Prostate cancer in men of African origin

    著者: , , - Nature Reviews Urology 2015 被引用: 124

  8. Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery

    著者: , , , , , , , , , , , , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2008 被引用: 209

  9. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin R. Loughlin, Grace L. Lu‐Yao, S. Bruce Malkowicz, Mark Mann, James Ryan Mark, Peter A. McCue, Martin Miner, Todd M. Morgan, Judd W. Moul, Ronald E. Myers, Sarah M. Nielsen, Elias Obeid, Christian P. Pavlovich, Stephen C. Peiper, David F. Penson, Daniel P. Petrylak, Curtis A. Pettaway, Robert Pilarski, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Mark E. Robson, Matt T. Rosenberg, Howard M. Sandler, Oliver Sartor, Edward M. Schaeffer, Gordon F. Schwartz, Mark S. Shahin, Neal D. Shore, Brian Shuch, Howard R. Soule, Scott A. Tomlins, Edouard J. Trabulsi, Robert G. Uzzo, Donald J. Vander Griend, Patrick C. Walsh, Carol J. Weil, Richard C. Wender, Leonard G. Gomella - Journal of Clinical Oncology 2017 被引用: 193

  10. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines

    著者: , , , , , , - International Journal of Oncology 2002 被引用: 163

  11. Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer

    著者: , , , , , , , , , - Prostate Cancer and Prostatic Diseases 2013 被引用: 91

  12. Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers

    著者: , , , , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2022 被引用: 38

  13. The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brittany A. Davidson, James K. DeOrio, Detlev Erdmann, Melissa M. Erickson, Bonita L. Funk, Jeffrey Gadsden, Mark J. Gage, Jeff R. Gingrich, Rachel A. Greenup, Christine Ha, Ashraf Habib, Ralph Abi Hachem, Ashley E. Hall, Matthew G. Hartwig, Laura J. Havrilesky, Mitchell T. Heflin, Courtney Holland, Scott T. Hollenbeck, Thomas J. Hopkins, Brant A. Inman, David W. Jang, Russel R. Kahmke, Isaac Karikari, Amie Kawasaki, Jacob A. Klapper, Christopher S. Klifto, Rebecca Klinger, Stuart J. Knechtle, Sandhya A. Lagoo-Deenadayalan, Walter T. Lee, Howard Levinson, Brian D. Lewis, Michael E. Lidsky, Michael E. Lipkin, Christopher R. Mantyh, Shelley R. McDonald, John Migaly, Timothy E. Miller, Suhail K. Mithani, Paul J. Mosca, Judd W. Moul, Thomas L. Novick, Steven A. Olson, Theodore N. Pappas, John J. Park, Andrew C. Peterson, Brett T. Phillips, Thomas J. Polascik, Peter Potash, Glenn M. Preminger, Rebecca A. Previs, Cary N. Robertson, Charles D. Scales Jr, Kevin N. Shah, Randall P. Scheri, Nazema Y. Siddiqui, Shayan Smani, Kevin W. Southerland, Michael T. Stang, Ayesha Syed, Alicja Szydlowska, Julie K.M. Thacker, Niccolò Terrando, Yanne Toulgoat-DuBois, Anthony G. Visco, Alison C. Weidner, Mamata Yanamadala, Sabino Zani Jr - Journal of Alzheimer s Disease 2020 被引用: 23

  14. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review

    著者: , , , , , , , , - Prostate Cancer and Prostatic Diseases 2022 被引用: 21

  15. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy

    著者: , , , , , , , , - Urology 2003 被引用: 271

  16. Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 215

  17. Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era

    著者: , , , , , - Journal of Clinical Oncology 2003 被引用: 457

  18. Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2003 被引用: 385

  19. Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer

    著者: , , , , , , , , , , , , , - JAMA 2007 被引用: 357

  20. PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCER

    著者: - The Journal of Urology 2000 被引用: 326

  21. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

    著者: , , , , , , , , , , , , - British Journal of Urology 2010 被引用: 258

  22. A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes

    著者: , , , , , , , , - European Urology 2011 被引用: 236

  23. Use of Glycosylated Hemoglobin to Identify Diabetics at High Risk for Penile Periprosthetic Infections

    著者: , , , , , - The Journal of Urology 1992 被引用: 160

  24. Phase 3, randomized, placebo‐controlled study of zibotentan (ZD4054) in patients with castration‐resistant prostate cancer metastatic to bone

    著者: , , , , , , , , , - Cancer 2012 被引用: 112